CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: In these initial studies, the NOD/SCID mouse (long-term)-repopulating LSC in AML and CML were found to reside preferentially in a CD34+/CD38− subset of the leukemic clone [14,15,16,30].